Vaccine Tensions Post-Brexit

This chapter examines the European Commission's new regulation for vaccine export authorization amid tensions with AstraZeneca and its implications for the UK's vaccine supply. It explores the complexities of vaccine distribution, the differences in contractual obligations between the UK and the EU, and the slow vaccination rollout in the EU compared to wealthier nations. Additionally, the chapter highlights the political landscape post-Brexit, discussing how vaccine disputes could further strain UK-EU relations.